PHARMASCIENCE INC v. TEVA CANADA INNOVATION ET AL
Summary of A-315-20
The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.
Federal Court Type: Appeal (S.27 - Final) - Others
Detected Type: Appeal (S.27 - Final) - Others [from T-2183-18 - Patented Medicines (NOC) Regulations [Actions]]
Parties and Lawyers:| Party | Firm | Lawyer |
|---|---|---|
| PHARMASCIENCE INC | Goodmans LLP | SCOPA, JORDAN |
| TEVA CANADA INNOVATION | ||
| TEVA CANADA LIMITED | ||
| YEDA RESEARCH AND DEVELOPMENT CO LTD | Goodmans LLP | SCOPA, JORDAN |
| Name | Number |
|---|---|
| 2760802 |
Patented Medicine: Glatiramer (Medicinal ingredients are based on automated analysis and should not be relied upon.)
Decisions
| Name | Date | Paragraph |
| PHARMASCIENCE INC. v.TEVA CANADA INNOVATION, et al. 2022 FCA 2 | Jan 6, 2022 | Over several weeks during the fall of 2020, Federal Court Justice Catherine M. Kane heard the trial of two patent infringement actions (see 2020 FC 1158) commenced pursuant to the Patent Medicines (Notice of Compliance) Regulations. ... Pharmascience argues that the Trial Judge erred with regard to the requirement for a proper disclosure by applying the disclosure requirement that is applicable to patents in general, and failing to recognize a heightened disclosure requirement applicable to inventions based on sound prediction. ... Pharmascience also argues in the alternative that, if the 802 Patent does not fail for lack of utility, it must fail for obviousness. It notes that the 802 Patent does not provide any results of experiments that could form the factual basis for a sound prediction of utility, and therefore the required factual basis and line of reasoning to support of a sound prediction must come from the common general knowledge of the person skilled in the art (PSA). ... For the reasons set out below, I would dismiss the present appeal. I find no reviewable error in the Trial Judge’s conclusions regarding either the utility or the inventiveness of the 802 Patent. |
This is an appeal from 2020 FC 1158 in T-2183-18. [Determination of the appeal is based on automated analysis and should not be relied upon.]
Docket Summary (Google Translate to English)
() 2022-09-29 - OttawaCopy of a decision of the Supreme Court delivered 29-SEP-2022 dismissing the motion to join three Federal Court of Appeal files received on 29-SEP-2022
Acknowledgment of Receipt received from both parties (via email) with respect to Judgment and Reasons for Judgment of the Court dated January 6, 2022. placed on file on 06-JAN-2022
Memorandum to file from FCA Registry dated 06-JAN-2022 Transmitting (via email) a copy of the Judgment and Reasons for Judgment of the Court dated January 6, 2022 to Justice Kane of FC, Actions section of FC and Prothonotary Tabib of FC. placed on file.
Reasons for Judgment rendered by The Honourable Mr. Justice Locke concurred in by The Honourable Mr. Justice Stratas The Honourable Madam Justice Monaghan dated 06-JAN-2022 The Court's decision is with regard to Appeal Filed on 06-JAN-2022 Copies sent to parties
Judgment dated 06-JAN-2022 rendered by The Honourable Mr. Justice Stratas The Honourable Mr. Justice Locke The Honourable Madam Justice Monaghan Matter considered with personal appearance The Court's decision is with regard to Appeal Result: dismissed with costs Filed on 06-JAN-2022 copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 320 page(s) 2 - 2 (Final decision)
This matter comes on for hearing on 24-NOV-2021 at Toronto before The Honourable Mr. Justice Stratas The Honourable Mr. Justice Locke The Honourable Madam Justice Monaghan Appearances: H.B. Radomski/Jordan Scopa/Jaclyn Tilak - 416-979-2211 for the appellant Bryan Norrie/Lesley Caswell/Devin Doyle/Jessica Sudbury - 613-903-5107 for respondents Language of Hearing: E Court Usher: Anne Brzuchalski Duration: on 24-NOV-2021 from 09:41 to 15:10 Courtroom : Courtroom No. 7-C - Toronto Court Registrar Nicole Hradsky Total duration: 5h 29min Before the Court: appeal Result: reserved Comments: Zoom and Tascam recorded Minutes of Hearing entered in Vol. 237 page(s) 247 - 252 Abstract of Hearing placed on file
Loose case law submitted by the Appellant. Forwarded to presiding panel. received on 24-NOV-2021
Loose case law provided by Respondents. Forwarded to presiding Panel. placed on file on 23-NOV-2021
Sealed envelope pursuant to Protective Agreement dated May 9, 2019 in Court Files T-2182-18/T-2183-18 on behalf of Respondents purporting to contain Teva's confidential compendium of oral argument Received on 23-NOV-2021
Solicitor's certificate of service on behalf of Jaclyn Tilak confirming service of doc#29 upon Respondent by email on 19-NOV-2021 filed on 19-NOV-2021
Appellant's Compendium (5 paper copies) (5 paper copies) filed on 19-NOV-2021
Covering letter from Appellant dated 04-NOV-2021 concerning ID 42, 43, and Doc. 28 placed on file on 04-NOV-2021
Solicitor's certificate of service on behalf of Jaclyn Tilak confirming service of ID 42 upon Respondents, Teva Canada Innovation and Teva Canada Limited by e-mail on 04-NOV-2021 filed on 04-NOV-2021
Sealed envelope pursuant to Order dated February 9, 2021 on behalf of Appellant purporting to contain Compendium of Pharmascience Inc (USB Key); includes 3 judges' copies Received on 04-NOV-2021
Sealed envelope pursuant to Order dated February 9, 2021 on behalf of Appellant purporting to contain Compendium of Pharmascience Inc. (2 vols.) includes 3 judges' copies Received on 04-NOV-2021
Covering letter from Appellant dated 26-OCT-2021 concerning Doc. Nos. 26 27 placed on file on 26-OCT-2021
Solicitor's certificate of service on behalf of Jaclyn Tilak confirming service of Doc. # 26 upon Respondents by email on 26-OCT-2021 filed on 26-OCT-2021
Sealed envelope pursuant to the Order dated February 9, 2021 on behalf of Appellant purporting to contain USB key of the Confidential Memorandum of Fact and Law - hyperlinked Filed on 26-OCT-2021
Covering letter from Respondent, Teva dated 25-OCT-2021 concerning Doc. Nos. 24 25 placed on file on 26-OCT-2021
Solicitor's certificate of service on behalf of Lesley Caswell confirming service of Teva's Confidential Compendium upon Appellant Respondent by electronic mail on 25-OCT-2021 filed on 26-OCT-2021
Sealed envelope pursuant to Order of the Court dated 09-FEB-2021 on behalf of Respondent, Teva purporting to contain Confidential Compendium (2 volumes) Filed on 26-OCT-2021
Acknowledgment of Receipt received from all parties with respect to Order doc 23 placed on file on 22-OCT-2021
Order (time and place) dated 22-OCT-2021 rendered by D. Lanteigne, Judicial Administrator fixing Appeal to be heard at Special Sitting in Ottawa (ONLINE) on 24-NOV-2021 to begin at 09:30 by way of video conference Filed on 22-OCT-2021 cc's sent to parties entered in J. & O. Book, volume 319 page(s) 17 - 17 Transmittal letters placed on file
Covering letter from Appellant dated 30-JUN-2021 concerning Doc. Nos. 21 22 placed on file on 30-JUN-2021
Solicitor's certificate of service on behalf of Jaclyn Tilak confirming service of doc. 21 upon Respondent by email on 30-JUN-2021 filed on 30-JUN-2021
Joint Book of Authorities consisting of 2 volume(s) on behalf of Appellant received by fax and filed on 30-JUN-2021 (with the consent of the Administrator)
Communication from Registry to Judicial Administrator dated 02-JUN-2021 re: Hearing to be fixed
Letter from the appellant dated 04-MAY-2021 concerning requisition for hearing and availability of parties. received on 04-MAY-2021
Solicitor's certificate of service on behalf of JACLYN TILAK confirming service of DOC 19 upon Respondent by E-MAIL on 04-MAY-2021 filed on 04-MAY-2021
Requisition for hearing - Appeal from Appellant filed on 04-MAY-2021
Covering letter from Respondents dated 14-APR-2021 concerning Doc. Nos. 17 18 placed on file on 14-APR-2021
Solicitor's certificate of service on behalf of Lesley Caswell confirming service of R's FACTUM dated 14-APR-2021 upon all parties by e-mail on 14-APR-2021 filed on 14-APR-2021
Memorandum of fact and law on behalf of Respondents filed on 14-APR-2021
Consent to rule 7 extension of time of 2days for the filing of the respondent's memorandum of fact and law. on behalf of all parties filed on 09-APR-2021
Public Version of the Memorandum of Fact and Law of Pharmascience Inc. dated 12-MAR-2021 filed on 24-MAR-2021
Covering letter from Appellant dated 15-MAR-2021 concerning Doc. Nos. 13 14 placed on file on 15-MAR-2021
Solicitor's certificate of service on behalf of Jaclyn Tilak confirming service of Doc. No. 14 upon all parties by e-mail on 12-MAR-2021 filed on 15-MAR-2021
Sealed envelope pursuant to Order of the Court rendered 9-FEB-2021 on behalf of Appellant purporting to contain CONFIDENTIAL Memorandum of Fact and Law of Pharmascience, Inc. (5 copies) Filed on 15-MAR-2021
Solicitor's certificate of service on behalf of Jaclyn Tilak confirming service of doc. #10 & 11 upon Respondent by e-mail on 12-FEB-2021 filed on 12-FEB-2021
USB KEY containing Appeal Book Public Version of the Appellant filed on 12-FEB-2021
Sealed envelope pursuant to Order of the Court dated February 12, 2021 on behalf of Appellant purporting to contain CONFIDENTIAL Appeal Book (USB KEY) Filed on 12-FEB-2021
Solicitor's certificate of service on behalf of Jaclyn Tilak confirming service of doc. 8 upon Respondent by email on 08-FEB-2021 filed on 10-FEB-2021
Agreement as to the content of the Appeal book from the appellant filed on 10-FEB-2021
Acknowledgment of Receipt received from both parties with respect to the two Orders of the Court dated 09-FEB-2021 placed on file on 09-FEB-2021
Order dated 09-FEB-2021 rendered by The Honourable Mr. Justice Webb Matter considered without personal appearance The Court's decision is with regard to Letter from Appellant dated 03-FEB-2021 re: Confidentiality order Result: granted Filed on 09-FEB-2021 entered in J. & O. Book, volume 315 page(s) 233 - 238
Order dated 09-FEB-2021 rendered by The Honourable Mr. Justice Webb Matter considered without personal appearance The Court's decision is with regard to Letter from Appellant dated 25-JAN-2021 re: Consolidation order Result: granted Filed on 09-FEB-2021 entered in J. & O. Book, volume 315 page(s) 230 - 232
Letter from the appellant dated 03-FEB-2021 on consent of the parties, seeking a confidentiality order in the above noted matter. Confidentiality order in underlying matter enclosed, along with draft received on 03-FEB-2021
Electronic communication dated January 26, 2021 regarding ID 8 letter placed on file on 26-JAN-2021
Letter from the appellant, with consent of the respondent dated 25-JAN-2021 seeking leave to consolidate A-315-20, A-316-20 & A-4-21 received on 25-JAN-2021
Memorandum to file from FCA Registry dated 12-JAN-2021 transmitting a copy of the Notice of Appeal to Justice Kane, to Prothonotary Tabib and to the Actions Section of FC placed on file.
Covering letter from Respondent dated 05-JAN-2021 concerning enclosed Notice of Appearance and Solicitor's Certificate of Service. placed on file on 07-JAN-2021
Solicitor's certificate of service on behalf of Lesley Caswell confirming service of Notice of Appearance upon Appellant by email on 05-JAN-2021 filed on 07-JAN-2021
Notice of appearance on behalf of Respondents, Teva Canada Innovation and Teva Canada Limited filed on 07-JAN-2021
Consent to the electronic service of all documents on behalf of all the parties filed on 07-JAN-2021
Solicitor's certificate of service on behalf of Jaclyn Tilak confirming service of Notice of Appeal upon Respondent by email on consent on 24-DEC-2020 filed on 05-JAN-2021
Notice of Appeal filed on 24-DEC-2020 against a decision Judgment of (Kane, J), dated 16-DEC-2020 in FC-T-2183-18 Tariff fee of $50.00 received: yes
The official version of the court proceeding information is available from the court websites directly: